ART4 and Ebola hemorrhagic fever: The co-expression of genes encoding Ebola and Lassa virus-specific glycoproteins was used to produce an RP vaccine that protects guinea pigs against Ebola and Lassa viral challenges, indicating that RP vaccines may protect against multiple diseases (13).